Tag: Acticor
Acticor Biotech: rebound after the previous day’s plunge – 04/26/2024 at 12:25 p.m.
(CercleFinance.com) – Acticor Biotech recorded a technical rebound on Friday on the Paris Stock Exchange after its tumble the day before, due to the failure of its phase 2/3 study…
Acticor Biotech will present the clinical results of its phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024 – 04/15/2024 at 6:00 p.m.
To receive all Acticor Biotech financial information in real time, request it by email to [email protected] • Results of the phase 2/3 ACTISAVE clinical study in the treatment of stroke…
Acticor Biotech raises 8 million euros for its stroke treatment – 03/15/2024 at 09:46
(AOF) – Acticor Biotech announces the success of its capital increase for a total gross amount of 8 million euros, through the issue of 2.56 million new shares at a…
Acticor Biotech launches a capital increase of at least €7 million – 03/14/2024 at 6:15 p.m.
• Capital increase consisting of an offer to qualified investors, categories of investors, as well as individual investors via the PrimaryBid platform• Subscription commitments from historic shareholders and new investors…
Acticor: ‘we are pleased to observe the market reaction’
(CercleFinance.com) – The French biopharmaceutical company Acticor Biotech found itself in the spotlight last week after the success of a clinical trial in the emergency treatment of stroke. Gilles Avenard,…
Acticor biotech: ‘we are pleased to observe the market reaction’
Read also (CercleFinance.com) – The French biopharmaceutical company Acticor Biotech found itself in the spotlight last week after the success of a clinical trial in the emergency treatment of stroke.…
Acticor biotech: The surge continues, hopes in strokes
Read also (CercleFinance.com) – Acticor Biotech shares continued to soar on the Paris Stock Exchange on Wednesday, the day after the biopharmaceutical company presented positive results in strokes. At 4:30…
Acticor Biotech launches a capital increase of 3 million euros – 11/27/2023 at 6:15 p.m.
(AOF) – Acticor Biotech announces the launch of a capital increase of approximately 3 million euros via the issue of new ordinary shares aimed at institutional and individual investors. The…
Acticor Biotech launches a capital increase of 3 million euros
(AOF) – Acticor Biotech announces the launch of a capital increase of approximately 3 million euros via the issue of new ordinary shares aimed at institutional and individual investors. The…
Acticor Biotech launches a capital increase of around 3 million euros – 11/27/2023 at 9:00 p.m.
To receive all Acticor Biotech financial information in real time, request it by email to [email protected] – Capital increase composed of an offer to qualified investors and an offer to…
Acticor Biotech participates in the 15th World Stroke Congress
By Alexandra Saintpierre Published on 10/12/2023 at 7:40 p.m. Photo credit © Acticor Biotech (Boursier.com) — The biotechnology…
Acticor: modification of the phase 2/3 study protocol – 09/15/2023 at 2:01 p.m.
(CercleFinance.com) – Acticor Biotech announced yesterday evening that it had decided to change the main criterion of its phase 2/3 study by retaining only one single criterion, namely the reduction…